<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37587510</PMID><DateCompleted><Year>2023</Year><Month>08</Month><Day>18</Day></DateCompleted><DateRevised><Year>2023</Year><Month>08</Month><Day>23</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2523-3106</ISSN><JournalIssue CitedMedium="Internet"><Volume>63</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Aug</Month><Day>16</Day></PubDate></JournalIssue><Title>Advances in rheumatology (London, England)</Title><ISOAbbreviation>Adv Rheumatol</ISOAbbreviation></Journal><ArticleTitle>CD4 T lymphocyte subsets display heterogeneous susceptibility to apoptosis induced by serum from patients with systemic lupus erythematosus.</ArticleTitle><Pagination><StartPage>40</StartPage><MedlinePgn>40</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1186/s42358-023-00321-3</ELocationID><Abstract><AbstractText Label="BACKGROUND">Serum from systemic lupus erythematosus (SLE) patients has been shown to induce T-lymphocyte (TL) apoptosis. Given that different cells of the immune system display different sensitivity to apoptosis, we set to evaluate the in vitro effect of SLE serum on regulatory T-cells (Treg), Th17, Th1 and Th2 from SLE patients and healthy controls.</AbstractText><AbstractText Label="METHODS">Peripheral blood mononuclear cells from SLE patients or normal controls were exposed to a pool of sera from SLE patients or normal controls. Annexin V was used to label cells in apoptosis or necrosis. Annexin V-labeled Treg, Th17, Th1 and Th2 cells were determined using flow cytometry.</AbstractText><AbstractText Label="RESULTS">Total CD3&#x2009;+&#x2009;and CD4&#x2009;+&#x2009;cells from SLE patients showed higher frequency of spontaneous apoptosis/necrosis, whereas Th1 cells from SLE patients presented reduced spontaneous apoptosis/necrosis rate as compared with cells from controls. Incubation with SLE serum induced increased frequency of apoptotic/necrotic CD3&#x2009;+&#x2009;, CD4&#x2009;+&#x2009;and Th2 cells from normal controls or from SLE patients as compared with cultures incubated with normal human serum (NHS) or without human serum at all. Incubation with SLE serum did not increase the apoptosis/necrosis rate in Th1 or Th17 cells. Treg cells from SLE patients were more prone to apoptosis/necrosis induced by SLE serum than Treg cells from normal individuals. Th1, Th2, and Th17 cells presented increased apoptosis rates in cultures without human serum.</AbstractText><AbstractText Label="CONCLUSION">Our findings indicate that the serum of patients with active SLE stimulates apoptosis of CD4&#x2009;+&#x2009;T cells in general and exhibit differentiated effects on CD4&#x2009;+&#x2009;T-cell subsets.</AbstractText><CopyrightInformation>&#xa9; 2023. Sociedade Brasileira de Reumatologia.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mesquita</LastName><ForeName>Fernanda Vieira</ForeName><Initials>FV</Initials><AffiliationInfo><Affiliation>Division of Rheumatology - Escola Paulista de Medicina, UNIFESP, Universidade Federal de S&#xe3;o Paulo, Rua Botucatu 740, SP, 04023-062, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ferreira</LastName><ForeName>Vanessa</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Division of Rheumatology - Escola Paulista de Medicina, UNIFESP, Universidade Federal de S&#xe3;o Paulo, Rua Botucatu 740, SP, 04023-062, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mesquita</LastName><ForeName>Danilo</ForeName><Initials>D</Initials><Suffix>Jr</Suffix><AffiliationInfo><Affiliation>Division of Rheumatology - Escola Paulista de Medicina, UNIFESP, Universidade Federal de S&#xe3;o Paulo, Rua Botucatu 740, SP, 04023-062, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Andrade</LastName><ForeName>Lu&#xed;s Eduardo Coelho</ForeName><Initials>LEC</Initials><Identifier Source="ORCID">0000-0001-8742-9931</Identifier><AffiliationInfo><Affiliation>Division of Rheumatology - Escola Paulista de Medicina, UNIFESP, Universidade Federal de S&#xe3;o Paulo, Rua Botucatu 740, SP, 04023-062, S&#xe3;o Paulo, Brazil. luis.andrade@unifesp.br.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>08</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Adv Rheumatol</MedlineTA><NlmUniqueID>101734172</NlmUniqueID><ISSNLinking>2523-3106</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017304">Annexin A5</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017304" MajorTopicYN="N">Annexin A5</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007963" MajorTopicYN="Y">Leukocytes, Mononuclear</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017209" MajorTopicYN="N">Apoptosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016176" MajorTopicYN="N">T-Lymphocyte Subsets</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009336" MajorTopicYN="N">Necrosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Apoptosis</Keyword><Keyword MajorTopicYN="N">Helper T cells</Keyword><Keyword MajorTopicYN="N">Regulatory T cells</Keyword><Keyword MajorTopicYN="N">Systemic lupus erythematosus</Keyword><Keyword MajorTopicYN="N">T lymphocyte</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>12</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>8</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>18</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>8</Month><Day>17</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>8</Month><Day>16</Day><Hour>23</Hour><Minute>43</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37587510</ArticleId><ArticleId IdType="doi">10.1186/s42358-023-00321-3</ArticleId><ArticleId IdType="pii">10.1186/s42358-023-00321-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Perniok A, Wedekind F, Herrmann M, Specker C, Schneider M. High levels of circulating early apoptic peripheral blood mononuclear cells in systemic lupus erythematosus. Lupus. 1998;7(2):113&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1191/096120398678919804</ArticleId><ArticleId IdType="pubmed">9541096</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang F, He Y, Zhai Z, Sun E. Programmed cell death pathways in the pathogenesis of systemic lupus erythematosus. J Immunol Res. 2019;2019:3638562.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2019/3638562</ArticleId><ArticleId IdType="pubmed">31871956</ArticleId><ArticleId IdType="pmc">6913273</ArticleId></ArticleIdList></Reference><Reference><Citation>Emlen W, Niebur J, Kadera R. Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosus. J Immunol Baltim Md. 1994;152(7):3685&#x2013;92.</Citation></Reference><Reference><Citation>Lorenz HM, Gr&#xfc;nke M, Hieronymus T, Herrmann M, K&#xfc;hnel A, Manger B, et al. In vitro apoptosis and expression of apoptosis-related molecules in lymphocytes from patients with systemic lupus erythematosus and other autoimmune diseases. Arthritis Rheum. 1997;40(2):306&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.1780400216</ArticleId><ArticleId IdType="pubmed">9041943</ArticleId></ArticleIdList></Reference><Reference><Citation>Bengtsson AA, Sturfelt G, Gullstrand B, Truedsson L. Induction of apoptosis in monocytes and lymphocytes by serum from patients with systemic lupus erythematosus&#x2014;an additional mechanism to increased autoantigen load? Clin Exp Immunol. 2004;135(3):535&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2249.2003.02386.x</ArticleId><ArticleId IdType="pubmed">15008990</ArticleId><ArticleId IdType="pmc">1808958</ArticleId></ArticleIdList></Reference><Reference><Citation>Bengtsson AA, Gullstrand B, Truedsson L, Sturfelt G. SLE serum induces classical caspase-dependent apoptosis independent of death receptors. Clin Immunol. 2008;126(1):57&#x2013;66.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2007.10.003</ArticleId><ArticleId IdType="pubmed">18036993</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H, Xu J, Ji X, Yang X, Sun K, Liu X, et al. The abnormal apoptosis of T cell subsets and possible involvement of IL-10 in systemic lupus erythematosus. Cell Immunol. 2005;235(2):117&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cellimm.2005.08.031</ArticleId><ArticleId IdType="pubmed">16226734</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang BC, Wang YS, Lin LC, Liu MF. Induction of apoptosis and cytokine gene expression in T-cell lines by sera of patients with systemic lupus erythematosus. Scand J Immunol. 1997;45(1):96&#x2013;102.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1365-3083.1997.d01-371.x</ArticleId><ArticleId IdType="pubmed">9010506</ArticleId></ArticleIdList></Reference><Reference><Citation>Tiefenthaler M, Bacher N, Linert H, M&#xfc;hlmann O, Hofer S, Sepp N, et al. Apoptosis of CD34+ cells after incubation with sera of leukopenic patients with systemic lupus erythematosus. Lupus. 2003;12(6):471&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1191/0961203303lu423oa</ArticleId><ArticleId IdType="pubmed">12873050</ArticleId></ArticleIdList></Reference><Reference><Citation>Klint C, Truedsson L, Andreasson A, Johansson I, Sturfelt G. Toxic effects of SLE serum on normal monocytes in vitro: cell death induced by apoptosis related to complement dysfunction. Lupus. 2000;9(4):278&#x2013;87.</Citation><ArticleIdList><ArticleId IdType="doi">10.1191/096120300680198999</ArticleId><ArticleId IdType="pubmed">10866099</ArticleId></ArticleIdList></Reference><Reference><Citation>Georgescu L, Vakkalanka RK, Elkon KB, Crow MK. Interleukin-10 promotes activation-induced cell death of SLE lymphocytes mediated by Fas ligand. J Clin Invest. 1997;100(10):2622&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI119806</ArticleId><ArticleId IdType="pubmed">9366578</ArticleId><ArticleId IdType="pmc">508464</ArticleId></ArticleIdList></Reference><Reference><Citation>Xue C, Lan-Lan W, Bei C, Jie C, Wei-Hua F. Abnormal Fas/FasL and caspase-3-mediated apoptotic signaling pathways of T lymphocyte subset in patients with systemic lupus erythematosus. Cell Immunol. 2006;239(2):121&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cellimm.2006.05.003</ArticleId><ArticleId IdType="pubmed">16808908</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X, Brunner T, Carter L, Dutton RW, Rogers P, Bradley L, et al. Unequal death in T helper cell (Th)1 and Th2 effectors: Th1, but not Th2, effectors undergo rapid Fas/FasL-mediated apoptosis. J Exp Med. 1997;185(10):1837&#x2013;49.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.185.10.1837</ArticleId><ArticleId IdType="pubmed">9151709</ArticleId><ArticleId IdType="pmc">2196321</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu Y, Iclozan C, Yamazaki T, Yang X, Anasetti C, Dong C, et al. Abundant c-Fas&#x2013;associated death domain&#x2013;like interleukin-1&#x2013;converting enzyme inhibitory protein expression determines resistance of T helper 17 cells to activation-induced cell death. Blood. 2009;114(5):1026&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2009-03-210153</ArticleId><ArticleId IdType="pubmed">19429865</ArticleId><ArticleId IdType="pmc">2721783</ArticleId></ArticleIdList></Reference><Reference><Citation>Funauchi M, Sugiyama M, SukYoo B, Ikoma S, Ohno M, Kinoshita K, et al. A possible role of apoptosis for regulating autoreactive responses in systemic lupus erythematosus. Lupus. 2001;10(4):284&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1191/096120301680416977</ArticleId><ArticleId IdType="pubmed">11341105</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan X, Yuan X, Zheng Y, Wang W, Shan J, Lin F, et al. Increased CD45RA+ FoxP3(low) regulatory T cells with impaired suppressive function in patients with systemic lupus erythematosus. PLoS ONE. 2012;7(4): e34662.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0034662</ArticleId><ArticleId IdType="pubmed">22506043</ArticleId><ArticleId IdType="pmc">3323568</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang J, Chu Y, Yang X, Gao D, Zhu L, Yang X, et al. Th17 and natural Treg cell population dynamics in systemic lupus erythematosus. Arthritis Rheum. 2009;60(5):1472&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.24499</ArticleId><ArticleId IdType="pubmed">19404966</ArticleId></ArticleIdList></Reference><Reference><Citation>Shin MS, Lee N, Kang I. Effector T-cell subsets in systemic lupus erythematosus: update focusing on Th17 cells. Curr Opin Rheumatol. 2011;23(5):444&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/BOR.0b013e328349a255</ArticleId><ArticleId IdType="pubmed">21720245</ArticleId><ArticleId IdType="pmc">3489922</ArticleId></ArticleIdList></Reference><Reference><Citation>Mesquita D, de Melo CW, Araujo J, Pucci F, Salmazi K, Kallas E, et al. Systemic lupus erythematosus exhibits a dynamic and continuum spectrum of effector/regulatory T cells. Scand J Rheumatol. 2011;40(1):41&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/03009742.2010.489229</ArticleId><ArticleId IdType="pubmed">20936986</ArticleId></ArticleIdList></Reference><Reference><Citation>Petri M, Orbai AM, Alarc&#xf3;n GS, Gordon C, Merrill JT, Fortin PR, et al. Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum. 2012;64(8):2677&#x2013;86.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.34473</ArticleId><ArticleId IdType="pubmed">22553077</ArticleId><ArticleId IdType="pmc">3409311</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>